Jump to content

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (Q43843458)

From Wikidata
scientific article published in January 2002
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
    scientific article published in January 2002

      Statements

      Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (English)
      Sanjiv S Agarwala
      Malcolm Mitchell
      Kristoffer Hellstrand
      John M Kirkwood

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit